Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BASILIXIMAB Cause Candida infection? 100 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 100 reports of Candida infection have been filed in association with BASILIXIMAB (Simulect). This represents 1.5% of all adverse event reports for BASILIXIMAB.

100
Reports of Candida infection with BASILIXIMAB
1.5%
of all BASILIXIMAB reports
47
Deaths
43
Hospitalizations

How Dangerous Is Candida infection From BASILIXIMAB?

Of the 100 reports, 47 (47.0%) resulted in death, 43 (43.0%) required hospitalization, and 17 (17.0%) were considered life-threatening.

Is Candida infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BASILIXIMAB. However, 100 reports have been filed with the FAERS database.

What Other Side Effects Does BASILIXIMAB Cause?

Cytomegalovirus infection (590) Drug ineffective (567) Off label use (567) Transplant rejection (554) Kidney transplant rejection (456) Product use in unapproved indication (428) Pyrexia (323) Diarrhoea (314) Multiple organ dysfunction syndrome (298) Polyomavirus-associated nephropathy (298)

What Other Drugs Cause Candida infection?

PREDNISONE (939) METHOTREXATE (782) RITUXIMAB (684) CYCLOPHOSPHAMIDE (662) TACROLIMUS (656) METHYLPREDNISOLONE (590) SECUKINUMAB (569) ADALIMUMAB (510) DEXAMETHASONE (506) PREDNISOLONE (499)

Which BASILIXIMAB Alternatives Have Lower Candida infection Risk?

BASILIXIMAB vs BAYER GENUINE ASPIRIN ORIGINAL STRENGTH BASILIXIMAB vs BAZEDOXIFENE\ESTROGENS, CONJUGATED BASILIXIMAB vs BCG VACCINE BASILIXIMAB vs BEBTELOVIMAB BASILIXIMAB vs BECLOMETHASONE

Related Pages

BASILIXIMAB Full Profile All Candida infection Reports All Drugs Causing Candida infection BASILIXIMAB Demographics